These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35807373)

  • 21. Nitrites as precursors of N-nitrosation in pharmaceutical samples - A trace level analysis.
    Jireš J; Douša M
    J Pharm Biomed Anal; 2022 May; 213():114677. PubMed ID: 35248987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS
    J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of genotoxic N-nitrosamines in active pharmaceutical ingredients and market authorized products in low abundance by means of liquid chromatography - tandem mass spectrometry.
    Vogel M; Norwig J
    J Pharm Biomed Anal; 2022 Sep; 219():114910. PubMed ID: 35779354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and simultaneous determination of sulfonate ester genotoxic impurities in drug substance by liquid chromatography coupled to tandem mass spectrometry: comparison of different ionization modes.
    Guo T; Shi Y; Zheng L; Feng F; Zheng F; Liu W
    J Chromatogr A; 2014 Aug; 1355():73-9. PubMed ID: 24997109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in Lopinavir and Ritonavir Active pharmaceutical ingredients by LC/MS/MS using electrospray ionization.
    Kakadiya PR; Reddy BP; Singh V; Ganguly S; Chandrashekhar TG; Singh DK
    J Pharm Biomed Anal; 2011 May; 55(2):379-84. PubMed ID: 21353429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A validated stability-indicative UPLC method for nilotinib hydrochloride for the determination of process-related and degradation impurities.
    Kondra SB; Madireddy V; Chilukuri M; Papadasu N; Jonnalagadda L
    J Chromatogr Sci; 2014 Sep; 52(8):880-5. PubMed ID: 24029617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitive, wide-range and high-throughput quantification of cyclosporine in whole blood using ultra-performance liquid chromatography coupled to tandem mass spectrometry and comparison with an antibody-conjugated magnetic immunoassay.
    Watanabe T; Tanaka R; Ono H; Suzuki Y; Tatsuta R; Itoh H
    Biomed Chromatogr; 2021 Aug; 35(8):e5128. PubMed ID: 33780006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients.
    Zech SG; Carr M; Mohemmad QK; Narasimhan NI; Murray C; Rozamus LW; Dalgarno DC
    J Antibiot (Tokyo); 2011 Sep; 64(9):649-54. PubMed ID: 21792211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of Genotoxic Impurity
    Xie B; Guo D; Mai B; Fan J
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364326
    [No Abstract]   [Full Text] [Related]  

  • 30. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry.
    Yu K; Little D; Plumb R; Smith B
    Rapid Commun Mass Spectrom; 2006; 20(4):544-52. PubMed ID: 16419023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new liquid chromatography-mass spectrometry approach for generic screening and quantitation of potential genotoxic alkylation compounds without derivatization.
    Cappiello A; Famiglini G; Palma P; Termopoli V; Trufelli H
    J Chromatogr A; 2012 Sep; 1255():286-90. PubMed ID: 22226454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
    Malati V; Reddy AR; Mukkanti K; Suryanarayana MV
    Talanta; 2012 Aug; 97():563-73. PubMed ID: 22841123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
    Azougagh M; Elkarbane M; Bakhous K; Issmaili S; Skalli A; Iben Moussad S; Benaji B
    Ann Pharm Fr; 2016 Sep; 74(5):358-69. PubMed ID: 27475309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical Method Development for 19 Alkyl Halides as Potential Genotoxic Impurities by Analytical Quality by Design.
    Lee K; Yoo W; Jeong JH
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The simultaneous quantification of phytosterols and tocopherols in liposomal formulations using validated atmospheric pressure chemical ionization- liquid chromatography -tandem mass spectrometry.
    Poudel A; Gachumi G; Badea I; Bashi ZD; El-Aneed A
    J Pharm Biomed Anal; 2020 May; 183():113104. PubMed ID: 32058287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Monteiro MA; de Lima PC; Novotny TS; Santana DS; Lima MED; Dantas ASCL; Ferreira LODS; de Souza MN; Maranho RLDN; Ochs SM
    J Pharm Sci; 2023 May; 112(5):1305-1314. PubMed ID: 36657719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of related impurities in an oral pharmaceutical formulation of tebipenem pivoxil using ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
    Xi P; Cao W; Li L; Shi W; Li F; Xu H; Xu X; Ke Y; Zhang J
    Rapid Commun Mass Spectrom; 2021 Aug; 35(16):e9129. PubMed ID: 34097785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of fascaplysin in rat plasma with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS): application to a pharmacokinetic study.
    Hu Z; Zhang M; He M; Fang B; Bao X; Yan X; Liang H; Wang H
    J Pharm Biomed Anal; 2019 Jul; 171():126-131. PubMed ID: 30986762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of novel RP-HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC-MS.
    Reddy Saddala MP; Konduru N; Gundla R; Kowtharapu LP
    Biomed Chromatogr; 2022 Dec; 36(12):e5486. PubMed ID: 36001450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.